SARS-CoV-2 promotes an unstable proinflammatory atherosclerotic plaque phenotype

J. Leberzammer (Frankfurt am Main)1, I. Kuznetsova (Giessen)2, E. G. Solomonidis (Frankfurt am Main)3, J. U. G. Wagner (Frankfurt am Main)3, D. Leistner (Frankfurt am Main)1, S. Dimmeler (Frankfurt am Main)4, S. Herold (Giessen)2, S. Cremer (Frankfurt am Main)1
1Universitätsklinikum Frankfurt Med. Klinik III - Kardiologie, Angiologie Frankfurt am Main, Deutschland; 2Department of Medicine V, Internal Medicine, Infectious Diseases and Infection Control Giessen, Deutschland; 3Goethe Universität Frankfurt am Main Institute of Cardiovascular Regeneration Frankfurt am Main, Deutschland; 4Goethe Universität Frankfurt am Main Zentrum für Molekulare Medizin, Institut für Kardiovaskuläre Regeneration Frankfurt am Main, Deutschland
Background: Viral respiratory infections, including SARS-CoV-2, are associated with an elevated risk of major adverse cardiovascular events (MACE). Although effects of SARS-CoV-2 on the vasculature and atherosclerotic plaque development have been proposed, definitive in vivo insights on how SARS-CoV-2 affects atherosclerotic plaque development have been limited.

Methods: LDLR-/- mice were fed with a high-fat diet for 8 weeks to develop moderate atherosclerotic plaques in the aorta. Mice were then infected with 1000 plaque-forming units of a mouse-adapted SARS-CoV-2 strain compared to mock infection. Histology (H&E, Sirius Red) of aortic roots were performed 28 days after viral injury to analyse plaque size and stability (fibrous cap/necrotic core ratio). Single-cell RNA sequencing (scRNA-seq) of aortas was performed to characterise the composition and phenotypes of atherosclerotic plaques after viral injury. Differentially expressed gene-, and ligand-receptor analyses (CellChat) were used as readouts.

Results: In the aortic root, we observed increased features of plaque instability after SARS-CoV-2 infection (fibrous cap/necrotic core ratio, mock: 1.19±0,32 vs. SARS-CoV-2: 2,7±0,42, p=0.013). In contrast, overall plaque size remained unchanged, consistent to the development of an unstable plaque phenotype. To gain molecular insights into how SARS-CoV-2 affects the composition and phenotype of atherosclerotic plaques, we performed scRNA-seq of plaques 28 days after SARS-CoV-2 infection. Here, we found a proinflammatory plaque phenotype characterised by enrichment of immune cells. Numbers of recruited Mhc-II+/Ccr2int macrophages (p=0.02) and dendritic cell (DC) subtypes (cDC1 p=0.02, CCR9+ DCs p=0.043, mature DCs: p=0.03) were increased, while resident macrophage numbers were unchanged. In addition, we also found increased T-cell subset numbers (Naive Cd4+ p=0.004, T-regs p=0.01, Naive Cd8+ p=0.0005, Il17+Cxcr6+ p=0.008). Investigating the transcriptomic profile of plaque immune cells revealed that proinflammatory cytokines were significantly upregulated in macrophages (Ccl2, Cxcl10, IL-1α), dendritic cells (Ccl5, Cxcl9), and T cells (TNF and TNF superfamily members). In addition, recently described immunoregulatory endothelial cells were induced, which express major histocompatibility complex class II genes and can present antigens to T cells, thereby facilitating their recruitment to the vessel wall. Ligand-receptor analysis revealed a significant upregulation (all pathways: p < 0.05 after differential expression testing) of various proatherogenic pathways, indicating a complex SARS-CoV-2-induced communication network. Here, endothelial cells showed increased recruitment signalling to macrophages and T-cells via the CXCL12-CXCR4 axis. In addition, we found complex cellular communication between immune and stromal cells, where macrophages communicated with fibroblasts via PDGF and TNF-related pathways, as well as through paracrine mechanisms mediated by CCL pathways. T-cells communicated with fibroblasts and endothelial cells via TGF-beta-related pathways. 

Conclusion: Our data, for the first time, dissects the in vivo effects of SARS-CoV-2 on the atherosclerotic vasculature, providing mechanistic insights into how SARS-CoV-2 infection affects the instability of atherosclerotic plaques.